Form 4: LeMaitre Vascular CFO Acquires Dividend Equivalent Rights

Joseph P. Pellegrino JR, CFO of LeMaitre Vascular, reports the acquisition of dividend equivalent rights related to restricted stock unit awards.

Summary

• Joseph P. Pellegrino JR, Chief Financial Officer of LeMaitre Vascular Inc. [LMAT], reported the acquisition of dividend equivalent rights on May 30, 2024.
• These rights are associated with restricted stock unit (RSU) and Performance Share Unit (PSU) awards granted between December 2019 and December 2023.
• The acquired dividend equivalent rights are economically equivalent to shares of LeMaitre Vascular's common stock.
• The CFO acquired 0.746, 1.4054, 2.6743, 4.0868, 4.0868, and 4.6567 dividend equivalent rights related to different grants.
• Following the transaction, Pellegrino directly owns 17.8147, 24.9903, 34.3451, 29.6683, 28.9853, and 10.1707 dividend equivalent rights related to different grants.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating standard executive compensation practices. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The acquisition of dividend equivalent rights by the CFO aligns his interests with those of the shareholders.
• The dividend equivalent rights are associated with previously granted RSU and PSU awards, indicating ongoing compensation and incentive plans.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Similar to other medical device companies such as Medtronic or Boston Scientific, LeMaitre Vascular uses equity-based compensation, including restricted stock units and performance share units, to incentivize and retain key executives.
• The granting of dividend equivalent rights is a common practice to ensure that executives receive the same economic benefits as common shareholders during the vesting period of their equity awards.
• The number of dividend equivalent rights granted is proportional to the underlying RSU and PSU awards, which is consistent with industry standards for equity compensation plans.

Stakeholder Impact

• The acquisition of dividend equivalent rights by the CFO has a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.
• It reflects the company's ongoing commitment to incentivizing its executives through equity-based compensation.

Key Dates